Université de Liège Réseau des Bibliothèques

Serveur institutionnel des thèses de doctorat

Nouvelles thèses
dans BICTEL/e - ULg
  • Nganou, Gerry - Importin 8 and cerebral corticogenesis : likely role in epileptogenesis / Importine 8 et corticogenèse cérébrale : un rôle probable dans l'épileptogenèse
  • Rowart, Pascal - Characterization of the Signaling Pathways Implicated in the AMPK-Mediated Assembly of Epithelial Tight Junctions/Caractérisation des voies de signalisation de l’AMPK impliquées dans la formation des jonctions serrées épithéliales
  • Charavet, Carole - Traitements Orthodontiques Novateurs Assistés par Chirurgie Ultrasonique Piézoélectrique / Innovative Orthodontic Treatment Using Piezosurgery
Présentation Recherche thèse Dépôt thèse Accès
Page de résumé pour ULgetd-01212014-122305

Auteur : Moermans, Catherine
E-mail de l'auteur : catherinemoermans@hotmail.com
URN : ULgetd-01212014-122305
Langue : Anglais/English
Titre : Lung function and airway inflammation monitoring after hematopoietic stem cell transplantation
Intitulé du diplôme : Doctorat en sciences médicales
Département : Médecine - Département des sciences cliniques
Jury :
Nom : Titre :
BARON, Frédéric Membre du jury/Committee Member
CATALDO, Didier Membre du jury/Committee Member
CORHAY, Jean-Louis Membre du jury/Committee Member
VERLEDEN, Geert Membre du jury/Committee Member
YACOUB-AGHA, Ibrahim Membre du jury/Committee Member
MOUTSCHEN, Michel Président du jury/Committee Chair
BEGUIN, Yves Promoteur/Director
LOUIS, Renaud Promoteur/Director
Mots-clés :
  • hematopoietic stem cell transplantation
  • airway inflammation
  • sputum
  • lung function
Date de soutenance : 2014-01-16
Type d'accès : Public/Internet
Résumé :

Allogeneic hematopoietic stem cell transplantation (HSCT) has been proposed to treat haematological malignancies since the 1960s. Unfortunately, pulmonary complications are frequent after this type of transplantation and are a major cause of post-transplant mortality.

Induced sputum (IS) and measurement of exhaled nitric oxide (FeNO) are non-invasive methods to investigate airway inflammation, which have been extensively used to assess airways inflammatory diseases. However, these procedures have not been studied in the context of HSCT.

In the first part of this work, in an attempt to detect modifications at airway level, we monitored lung function and airway inflammation in 182 patients who underwent HSCT. We prospectively measured FEV1, FVC, DLCO, KCO, TLC, RV, FeNO as well as sputum cell counts before and 3, 6, 12, 24 and 36 months after HSCT. We observed that there was a progressive loss in lung function after HSCT featuring a mild restrictive pattern while bronchiolitis obliterans rarely occurred (3.5%). Moreover, the patients undergoing a HSCT exhibited a high sputum neutrophil count, which was sustained over all the period of observation. By contrast, the FeNO value remained in the accepted normal range throughout the post-transplant course.

The myeloablative (MA) conditioning was associated with early rise of sputum neutrophils and greater alteration in lung function over the first year. Overall survival at 1 year after HSCT were 71% and none of the baseline functional and airway inflammation features had a prognostic value for survival at one year.

In a second part of our work, we measured Th1, Th2 and Th17 cytokines in the IS supernatant in order to better characterize the airway inflammatory process in patients with HSCT. Then, we compared the results with those from healthy subjects matched for age and tobacco habits and with patients suffering from chronic obstructive pulmonary disease (COPD), a chronic airway inflammatory disease also marked by a airway neutrophilic inflammation. We observed that that patients undergoing HSCT display raised sputum levels of IL-6 and IL-8 compared to healthy subjects though the levels remained lower than those found in COPD.

In the third part of our work, we assessed the impact of mesenchymal stem cell (MSC) co-infusion on lung function after HSCT. Indeed, MSC are used to promote engraftment and prevent graft-versus-host-disease in the context of HSCT but were shown to have opposite effects on lungs after systemic administration in animals. Their effects have never been studied in human after HSCT. Thus, we monitored lung functions, FeNO values, the occurrence of pulmonary infections and cytomegalovirus (CMV) reactivation in 30 patients who received an allogeneic unrelated HSCT after non-myeloabaltive (NMA) conditioning with MSC co-infusion. They were compared with 28 patients undergoing the same type of transplantation and conditioning but without MSC infusion. The impact of MSC on pulmonary infections and CMV reactivation was analysed by uni and multivariate Cox models adjusted for competing risks. The principal observations were that MSC were safe at lung level after HSCT and did not lead to lung function changes 1 year post transplantation. However, MSC could promote pulmonary infections involving the need for a close monitoring of their occurrence.


There was a progressive loss in lung function after HSCT, featuring a restrictive pattern. Myeloablative conditioning was associated with early rise of sputum neutrophils and greater alteration in lung function over the first year. Moreover, patients undergoing HSCT exhibited a neutrophilic airway inflammation associated with raised sputum levels of IL-6 and IL-8, a picture similar but developed to a lesser extent of what is seen in COPD.

Finally, MSC co-infusion did not induce pulmonary deterioration 1 year after HSCT with NMA conditioning. MSC appeared to be safe for the lung but close monitoring of pulmonary infections remains essential.

Autre version :
Fichiers :
Nom du fichier Taille Temps de chargement évalué (HH:MI:SS)
Modem 56K ADSL
[Public/Internet] these.pdf 37.53 Mb 01:29:21 00:03:20

Bien que le maximum ait été fait pour que les droits des ayants-droits soient respectés, si un de ceux-ci constatait qu'une oeuvre sur laquelle il a des droits a été utilisée dans BICTEL/e ULg sans son autorisation explicite, il est invité à prendre contact le plus rapidement possible avec la Direction du Réseau des Bibliothèques.

Parcourir BICTEL/e par Auteur|Département | Rechercher dans BICTEL/e

© Réseau des Bibliothèques de l'ULg, Grande traverse, 12 B37 4000 LIEGE